Entecavir soft capsule
A technology of entecavir and soft capsules, applied in the field of entecavir soft capsules, can solve problems such as low penetration rate, achieve low penetration rate, increase solubility and stability, and increase storage stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Weigh 1975.0 mg of polyethylene glycol 400, place it in a water bath and heat it to 70°C to keep it warm, then add 5.0 mg of entecavir to it and stir until it dissolves. To form a solution ①, then add 20 mg of Povidone K30 to the solution ①, stir and dissolve. If preservative is added, add preservative and stir to dissolve. Serve the entecavir soft capsule content composition, inject this composition into the soft capsule preparation machine, adjust the injection volume of the machine, so that the content of the entecavir soft capsule content composition of 0.2g per soft capsule contains 0.5mg of the active ingredient of entecavir.
Embodiment 2
[0029] According to Example 1, the following soft capsules with the following components were prepared by simultaneous polymerization, except that the amount of povidone used as a solubilizer was different or the preservative was added:
[0030] 2-a component content (mg / capsule)
[0031] Entecavir 0.5
[0032] Polyethylene glycol 400 197.0
[0033] Povidone K30 2.5
[0034] Total 200.0
[0035] 2-b component content (mg / capsule)
[0036] Entecavir 0.5
[0037] Polyethylene glycol 400 198.5
[0038] Povidone K30 1.0
[0039] Total 200.0
[0040] 2-c component content (mg / capsule)
[0041] Entecavir 0.5
[0042] Polyethylene glycol 400 196.5
[0043] Povidone K30 3.0
[0044] Total 200.0
[0045] 2-d component content (mg / capsule)
[0046] Entecavir 0.5
[0047] Polyethylene glycol 400 196.5
[0048] Propy...
Embodiment 3
[0052] Weigh 1969 mg of polyethylene glycol 400, place it in a water bath and heat it to 70°C to keep it warm, then add 5.0 mg of entecavir to it and stir until it is dissolved. To form a solution ①, then add 20 mg of Povidone K30 to the solution ①, stir and dissolve, to form a solution ②, add poloxamer 188 6 mg, stir at high speed, and stir until a milky white liquid. If adding preservative, add preservative, stir and dissolve. Serve the entecavir soft capsule content composition, inject this composition into the soft capsule preparation machine, adjust the injection volume of the machine, so that the content of the entecavir soft capsule content composition of 0.2g per soft capsule contains 0.5mg of the active ingredient of entecavir.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 